Surgical treatment of pulmonary metastasis from hepatocellular carcinoma

Koide Norimasa, Kondo Haruhiko, Suzuki Kenji, Hisao Asamura, Shimada Kazuaki, Tsuchiya Ryosuke

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background/Aims: The lung is one of the most common sites of extrahepatic spread from hepatocellular carcinoma (HCC). The aim of this study was to evaluate the efficacy of surgical management in patients with pulmonary metastasis from HCC. Methodology: Fourteen patients with pulmonary metastases arising from HCC underwent surgery at the National Cancer Center Hospital between 1980 and 2001. The clinical and pathological data were analyzed retrospectively. Results: Four patients were still alive and none of them had evidence of recurrent disease. Ten patients had died with recurrent HCC. The postoperative morbidity and mortality rates were low. The mean overall survival was 42.7 months (range, 8-87). The mean survival after initial thoracotomy was 21.6 months (range, 1-66). The 1-, 2-, and 5-year survival rates after metastasectomy were 71.4%, 44.6%, and 26.8%, respectively. Conclusions: Surgical treatment is appropriate option in selected patients for pulmonary metastasis arising from HCC, and might prolong survival.

Original languageEnglish
Pages (from-to)152-156
Number of pages5
JournalHepato-Gastroenterology
Volume54
Issue number73
Publication statusPublished - 2007 Jan
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Neoplasm Metastasis
Lung
Survival
Metastasectomy
Therapeutics
Cancer Care Facilities
Thoracotomy
Survival Rate
Morbidity
Mortality

Keywords

  • Hepatocellular carcinoma
  • Pulmonary metastasis
  • Pulmonary resection
  • Survival

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Norimasa, K., Haruhiko, K., Kenji, S., Asamura, H., Kazuaki, S., & Ryosuke, T. (2007). Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. Hepato-Gastroenterology, 54(73), 152-156.

Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. / Norimasa, Koide; Haruhiko, Kondo; Kenji, Suzuki; Asamura, Hisao; Kazuaki, Shimada; Ryosuke, Tsuchiya.

In: Hepato-Gastroenterology, Vol. 54, No. 73, 01.2007, p. 152-156.

Research output: Contribution to journalArticle

Norimasa, K, Haruhiko, K, Kenji, S, Asamura, H, Kazuaki, S & Ryosuke, T 2007, 'Surgical treatment of pulmonary metastasis from hepatocellular carcinoma', Hepato-Gastroenterology, vol. 54, no. 73, pp. 152-156.
Norimasa K, Haruhiko K, Kenji S, Asamura H, Kazuaki S, Ryosuke T. Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. Hepato-Gastroenterology. 2007 Jan;54(73):152-156.
Norimasa, Koide ; Haruhiko, Kondo ; Kenji, Suzuki ; Asamura, Hisao ; Kazuaki, Shimada ; Ryosuke, Tsuchiya. / Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. In: Hepato-Gastroenterology. 2007 ; Vol. 54, No. 73. pp. 152-156.
@article{f39d0e1da0a54834a7e3bead3d97a99f,
title = "Surgical treatment of pulmonary metastasis from hepatocellular carcinoma",
abstract = "Background/Aims: The lung is one of the most common sites of extrahepatic spread from hepatocellular carcinoma (HCC). The aim of this study was to evaluate the efficacy of surgical management in patients with pulmonary metastasis from HCC. Methodology: Fourteen patients with pulmonary metastases arising from HCC underwent surgery at the National Cancer Center Hospital between 1980 and 2001. The clinical and pathological data were analyzed retrospectively. Results: Four patients were still alive and none of them had evidence of recurrent disease. Ten patients had died with recurrent HCC. The postoperative morbidity and mortality rates were low. The mean overall survival was 42.7 months (range, 8-87). The mean survival after initial thoracotomy was 21.6 months (range, 1-66). The 1-, 2-, and 5-year survival rates after metastasectomy were 71.4{\%}, 44.6{\%}, and 26.8{\%}, respectively. Conclusions: Surgical treatment is appropriate option in selected patients for pulmonary metastasis arising from HCC, and might prolong survival.",
keywords = "Hepatocellular carcinoma, Pulmonary metastasis, Pulmonary resection, Survival",
author = "Koide Norimasa and Kondo Haruhiko and Suzuki Kenji and Hisao Asamura and Shimada Kazuaki and Tsuchiya Ryosuke",
year = "2007",
month = "1",
language = "English",
volume = "54",
pages = "152--156",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "73",

}

TY - JOUR

T1 - Surgical treatment of pulmonary metastasis from hepatocellular carcinoma

AU - Norimasa, Koide

AU - Haruhiko, Kondo

AU - Kenji, Suzuki

AU - Asamura, Hisao

AU - Kazuaki, Shimada

AU - Ryosuke, Tsuchiya

PY - 2007/1

Y1 - 2007/1

N2 - Background/Aims: The lung is one of the most common sites of extrahepatic spread from hepatocellular carcinoma (HCC). The aim of this study was to evaluate the efficacy of surgical management in patients with pulmonary metastasis from HCC. Methodology: Fourteen patients with pulmonary metastases arising from HCC underwent surgery at the National Cancer Center Hospital between 1980 and 2001. The clinical and pathological data were analyzed retrospectively. Results: Four patients were still alive and none of them had evidence of recurrent disease. Ten patients had died with recurrent HCC. The postoperative morbidity and mortality rates were low. The mean overall survival was 42.7 months (range, 8-87). The mean survival after initial thoracotomy was 21.6 months (range, 1-66). The 1-, 2-, and 5-year survival rates after metastasectomy were 71.4%, 44.6%, and 26.8%, respectively. Conclusions: Surgical treatment is appropriate option in selected patients for pulmonary metastasis arising from HCC, and might prolong survival.

AB - Background/Aims: The lung is one of the most common sites of extrahepatic spread from hepatocellular carcinoma (HCC). The aim of this study was to evaluate the efficacy of surgical management in patients with pulmonary metastasis from HCC. Methodology: Fourteen patients with pulmonary metastases arising from HCC underwent surgery at the National Cancer Center Hospital between 1980 and 2001. The clinical and pathological data were analyzed retrospectively. Results: Four patients were still alive and none of them had evidence of recurrent disease. Ten patients had died with recurrent HCC. The postoperative morbidity and mortality rates were low. The mean overall survival was 42.7 months (range, 8-87). The mean survival after initial thoracotomy was 21.6 months (range, 1-66). The 1-, 2-, and 5-year survival rates after metastasectomy were 71.4%, 44.6%, and 26.8%, respectively. Conclusions: Surgical treatment is appropriate option in selected patients for pulmonary metastasis arising from HCC, and might prolong survival.

KW - Hepatocellular carcinoma

KW - Pulmonary metastasis

KW - Pulmonary resection

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=34047155495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047155495&partnerID=8YFLogxK

M3 - Article

C2 - 17419251

AN - SCOPUS:34047155495

VL - 54

SP - 152

EP - 156

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 73

ER -